Treatment Induced Cytotoxic T-Cell Modulation in Multiple Myeloma Patients

The biology of plasma cell dyscrasias (PCD) involves both genetic and immune-related factors. Since genetic lesions are necessary but not sufficient for Multiple Myeloma (MM) evolution, several authors hypothesized that immune dysfunction involving both B and T cell counterparts plays a key role in...

Cijeli opis

Bibliografski detalji

Glavni autori:	Gregorio Barilà, Laura Pavan, Susanna Vedovato, Tamara Berno, Mariella Lo Schirico, Massimiliano Arangio Febbo, Antonella Teramo, Giulia Calabretto, Cristina Vicenzetto, Vanessa Rebecca Gasparini, Anna Fregnani, Sabrina Manni, Valentina Trimarco, Samuela Carraro, Monica Facco, Francesco Piazza, Gianpietro Semenzato, Renato Zambello
Format:	Artigo
Jezik:	Inglês
Izdano:	Frontiers Media S.A. 2021-06-01
Serija:	Frontiers in Oncology
Teme:	multiple myeloma immunophenotyping treatment lenalidomide ASCT-autologous stem cell transplantation cytotoxic response
Online pristup:	https://www.frontiersin.org/articles/10.3389/fonc.2021.682658/full
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!